These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6860498)

  • 21. [New potential of estrogen and progesterone receptor assay in cytological smears sampled from breast cancer patients].
    Ellinidi VN; Anikeeva NV; Goncharova OA; Novik VI
    Vopr Onkol; 2004; 50(3):355-6. PubMed ID: 15318713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclic AMP-binding protein and estrogen receptor: antagonism during nuclear translocation in a hormone-dependent mammary tumor.
    Bodwin JS; Hirayama PH; Cho-Chung YS
    Biochem Biophys Res Commun; 1981 Dec; 103(4):1349-55. PubMed ID: 6277332
    [No Abstract]   [Full Text] [Related]  

  • 23. WT1, estrogen receptor, and progesterone receptor as markers for breast or ovarian primary sites in metastatic adenocarcinoma to body fluids.
    Lee BH; Hecht JL; Pinkus JL; Pinkus GS
    Am J Clin Pathol; 2002 May; 117(5):745-50. PubMed ID: 12090423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasminogen-activating activity: association with steroid binding by cytosols of human breast cancers.
    Sutherland DJ
    J Natl Cancer Inst; 1980 Jan; 64(1):3-7. PubMed ID: 6928046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
    Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
    Acta Oncol; 2009; 48(4):522-31. PubMed ID: 19173092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytoplasmic and nuclear estrogen and progesterone receptors in male breast cancer.
    Pegoraro RJ; Nirmul D; Joubert SM
    Cancer Res; 1982 Nov; 42(11):4812-4. PubMed ID: 7127316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of sex steroid receptors in obstetrics and gynecology.
    Roberts DK; Van Sickle M; Kelly RW
    Obstet Gynecol Annu; 1983; 12():61-78. PubMed ID: 6866353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunochemical demonstration of immunoreactive insulin in human breast cancer.
    Castro A; Ziegels-Weissman J; Buschbaum P; Voigt W; Morales A; Nadji M
    Res Commun Chem Pathol Pharmacol; 1980 Jul; 29(1):171-82. PubMed ID: 6996061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen receptor-negative, progesterone receptor-positive breast carcinoma: poor clinical outcome.
    Keshgegian AA; Cnaan A
    Arch Pathol Lab Med; 1996 Oct; 120(10):970-3. PubMed ID: 12046611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogen binding sites in the nucleus of normal and malignant human tissue: optimization of an exchange assay for the measurement of specific binding.
    Syne JS; Markaverich BM; Clark JH; Panko WB
    Cancer Res; 1982 Nov; 42(11):4443-8. PubMed ID: 7127286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship of cytoplasmic and nuclear estrogen receptors and progesterone receptors in human breast cancer.
    Romić-Stojković R; Gamulin S
    Cancer Res; 1980 Dec; 40(12):4821-5. PubMed ID: 7438115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The oestrogen receptor-negative/progesterone receptor-positive breast tumour: a biological entity or a technical artefact?
    Rhodes A; Jasani B
    J Clin Pathol; 2009 Jan; 62(1):95-6. PubMed ID: 19103868
    [No Abstract]   [Full Text] [Related]  

  • 33. Estradiol and progesterone binding in uterine leiomyomata and in normal uterine tissues.
    Wilson EA; Yang F; Rees ED
    Obstet Gynecol; 1980 Jan; 55(1):20-4. PubMed ID: 7352057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclic AMP binding proteins and prognosis in breast cancer.
    Miller WR; Elton RA; Dixon JM; Chetty U; Watson DM
    Br J Cancer; 1990 Feb; 61(2):263-6. PubMed ID: 2155642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A magic bullet for breast cancer.
    Hubbard D
    J Nucl Med; 1986 Feb; 27(2):305. PubMed ID: 3712047
    [No Abstract]   [Full Text] [Related]  

  • 36. 25-Hydroxycholecalciferol receptors in human breast cancer.
    Murphy LC; Wild J; Posen S; Stone G
    Br J Cancer; 1979 May; 39(5):531-5. PubMed ID: 486309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of peroxidase activity in human breast cancer with oestradiol and progesterone receptors.
    Liel Y; Marbach M; Bearman JE; Feldman B; Glick SM; Levy J
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1389-90. PubMed ID: 6891935
    [No Abstract]   [Full Text] [Related]  

  • 38. Cellular estrogen and progesterone receptors in mammary carcinoma.
    Lee SH
    Am J Clin Pathol; 1980 Mar; 73(3):323-9. PubMed ID: 7361711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human breast tumour cytosol oestrogen receptor binding to oligo(dT)-cellulose.
    Myatt L; White JO; Fernandez MD; Burn JI
    Br J Cancer; 1982 Jun; 45(6):964-7. PubMed ID: 7093126
    [No Abstract]   [Full Text] [Related]  

  • 40. Relationship of hormone dependency to estrogen receptor and adenosine 3',5'-cyclic monophosphate-binding proteins in rat mammary tumors.
    Bodwin JS; Clair T; Cho-Chung YS
    J Natl Cancer Inst; 1980 Feb; 64(2):395-8. PubMed ID: 6928231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.